BSL-2 is designed for work with agents that pose moderate hazards to personnel and the environment. These agents are associated with human diseases that are generally treatable or preventable. Agents ...

When the COVID-19 pandemic arrived in the United States in 2020, the American research community experienced a sudden spike in funding. Universities, pharmaceutical companies, and state and federal ...

Not long after SARS-CoV-2 was first identified in December 2019 as the cause of an alarming cluster of severe pneumonia cases in central China, the U.S. Centers for Disease Control and Prevention ...

ENFIELD, Conn.--(BUSINESS WIRE)--Eppendorf is proud to announce they have received Connecticut State approval to conduct Biosafety Level 2 (BL2) infectious disease related research. This greatly ...